title: Modulation of calcium phosphate formation by phosphatidate-containing anionic liposomes.
abstract: Liposome prepared from 7:2:1 molar mixtures of phosphatidylcholine, dicetyl phosphate, and cholesterol to which 1-20 mole % dioleoylphosphatidic acid (DOPA) was added were used to examine the effect of membrane-bound monoester phosphatidate anions on calcium phosphate formation in aqueous solutions at 22 degrees C, pH 7.4 and 240 mOsm. Results showed that up to 20 mole % DOPA in the liposomal envelope did not initiate mineralization in solutions made metastable with 2.25 mM CaCl2 and 1.50 mM KH2PO4. Results alos revealed that precipitation induced in metastable solutions by the seeding action of intraliposomally formed mineral was measurably reduced with as little as 1 mole % DOPA and completely suppressed with 5 mole % DOPA. In contrast, 10 mole % concentrations of diester phosphate lipids either had no effect on extraliposomal precipitation (e.g., phosphatidylglycerol and phosphatidylinositol) or, as reported previously for phosphatidylserine) only partially reduced the amount of precipitate formed. Transmission electron microscopical analysis suggests that DOPA-containing lipid bilayers adhering to the seed crystals inhibited extraliposomal mineralization by encapsulating the crystals within the liposomes and/or by blocking potential growth sites on the crystal faces. The polar head group of DOPA, being more negatively charged and sterically less encumbered than diester phosphate ligands, most probably was responsible for this adherence of the lipid bilayers to the crystal surfaces.
authors.affiliation: National Institute of Dental Research, Bethesda, MD 20892.
authors.forename: E D
authors.initials: ED
authors.lastname: Eanes
authors.forename: A W
authors.initials: AW
authors.lastname: Hailer
authors.forename: B R
authors.initials: BR
authors.lastname: Heywood
mesh_terms: D000818:Animals; D000838:Anions / Q000032:analysis; D002118:Calcium / Q000378:metabolism; D002130:Calcium Phosphates / Q000378:metabolism*; D008081:Liposomes / Q000032:analysis / Q000494:pharmacology; D008563:Membrane Lipids / Q000502:physiology*; D010755:Organophosphates / Q000494:pharmacology; D010712:Phosphatidic Acids / Q000032:analysis / Q000494:pharmacology; D010715:Phosphatidylglycerols / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000494:pharmacology; D010718:Phosphatidylserines / Q000494:pharmacology
chemical_list: D000838:Anions; D002130:Calcium Phosphates; D008081:Liposomes; D008563:Membrane Lipids; D010755:Organophosphates; D010712:Phosphatidic Acids; D010715:Phosphatidylglycerols; D010716:Phosphatidylinositols; D010718:Phosphatidylserines; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C037657:dioleoylphosphatidic acid; C002290:dicetylphosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D002118:Calcium